Since their discovery in the 1950s, adenoviruses have been increasingly recognized as versatile and powerful gene therapy and vaccine development tools. By 1994, the...
In the ongoing Omicron era, a new COVID-19 antibody could renew optimism for urgently required SARS-CoV-2 monoclonal therapies. Over the last three years, various...
